Araceli Biosciences

Tigard, OR · Founded 2020 · Privately Held (backing)

Developer of advanced imaging technologies intended to enhance the drug discovery process for researchers. Araceli Biosciences is based in Tigard, OR and was founded in 2020. It was valued at $27 million at its seed round in Nov 2025, the last priced event on record. It has raised $14.5 million across 2 recorded rounds; the latest was a $12.2 million early-stage round in Dec 2024.

PMV mark · valuation
$27.0M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$14.5M
Last round
Early Stage VC
Dec 2024
What is Araceli Biosciences worth?
$27.0MPrivateMarketView mark · Oct 2026

Valued at $27.0M at its seed round, Nov 2025. Nothing has traded since.

Free account
More of Araceli Biosciences with a free account
  • ·Watch Araceli Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Araceli Biosciences funding history

2 rounds
DateRoundRaisedPost-money
Dec 2024Early Stage VC$12.2M▮
Apr 2023Seed Round$2.2M▮
Unlock post-money valuations

Membership and data by Private Market View

Araceli Biosciences valuation

Araceli Biosciences was valued at $27 million at its seed round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Araceli Biosciences raised?

Araceli Biosciences has raised $14.5 million across 2 recorded rounds since 2023. The largest was a $2.2 million seed round in Apr 2023; the most recent was a $12.2 million early-stage round in Dec 2024.

Araceli Biosciences has filed 3 Form Ds with the SEC since 2023, most recently in Dec 2025 ($12.2 million sold to 28 investors).

How Araceli Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Araceli Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Araceli Biosciences

What is Araceli Biosciences worth?
Araceli Biosciences is valued at $27.0M as of Oct 2026. Valued at $27.0M at its seed round, Nov 2025. Nothing has traded since.
How much has Araceli Biosciences raised?
Araceli Biosciences has raised $14.5M in total funding across 2 recorded rounds.
When did Araceli Biosciences last raise?
Araceli Biosciences last raised in Dec 2024 (Early Stage VC), raising $12.2M.